1. In this study, motor strength of the subjects was measured with MMT-MRC scoring system. The reason given by the authors was that, this method can measure the strength of muscle effectively in stroke patients ( serum concentrations of IGF-1 and IGFBP-3 are associated with weakness in people with chronic stroke. The conclusion was "Low serum concentrations of IGF-1 and IGFBP-3, deficits in neuromuscular performance, selective muscle atrophy, and decreased agonist muscle activation were found in the group with chronic hemi paresis post stroke. Both hemorrhagic and ischemic stroke were considered, and the data reflect a chronic post stroke population with good function". See: http://www.ncbi.nlm.nih.gov/pubmed/24578521 c. The Guggenmos's article was a review of Restoration of function after brain damage using a neural prosthesis. The article concluded that the repair of motors (muscles) caused by stroke, can occur after implantation of microelectrodes in the cerebral cortex. See: http://www.ncbi.nlm.nih.gov/ pubmed/24324155 d. When read more detail the 3 references mentioned above, the claim of authors that the motor function improvement of chronic ischemic stroke after the IAHF therapy, was not proven. There was no reference that explained it.
3. In the remaining references, there also was nothing of reference to support the study result.
4. The authors concluded that, IAHF treatment can significantly improve muscle strength. So far IAHF was suggested to be a new potential stroke therapy with good prognostic outcome and wider time window.
CONCLUSION OF OUR REVIEWS:
Based on all references mentioned previously, it is concluded that this study has a very weak scientific basis. No references which support the study result, that IAHF can improve motor functions in patients with chronic ischemic stroke.
Thank you very much for the attention.
